A generic starting with A that is FDA equivalent implies what about therapeutic effect?

• A. Should produce the same therapeutic effect as the reference product
• B. Cannot be trusted due to potential differences
• C. Has unknown status
• D. Is not available in the market

Answer: (A)

The key idea is bioequivalence. When a generic starts with A and is FDA-equivalent, it has been shown to be bioequivalent to the reference product. This means it delivers the same amount of active drug into the bloodstream in a comparable time frame, for the same dosage form and strength. Because of that, the therapeutic effect should be the same as the reference product when used as directed. Inactive ingredients can differ, but they don’t alter the overall efficacy for most people, and regulatory standards ensure similar safety and effectiveness.